Injective
Why Injective is down 2.2% in the last hour
Analysis
Injective (INJ) slipped 2.2% over the past hour as traders digested regulatory-related headlines around the project’s push into real estate tokenization, which can heighten near-term uncertainty and prompt profit-taking. AMBCrypto reported on Injective “eyeing $10B real estate tokenization” and framed it through a regulatory lens, which may have contributed to a cautious short-term reaction despite the longer-term adoption narrative.
Contributing Factors (1)
Injective eyes $10B real estate tokenization – Will INJ demand rise?
Injective [INJ] has been among the tokens that have caught investors’ attention as the blockchain doubles down on its focus on real-world assets (RWAs), which have gained traction recently. Investors...
Move Details
Explanation Confidence
Moderate confidence. Multiple factors may be contributing.